Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38526 - 38550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	SLC2A3	6515	upregulated	entinostat results in increased expression of SLC2A3 mRNA	12p13.31	A21037
Entinostat	Investigational	SLC30A8	169026	upregulated	entinostat results in increased expression of SLC30A8 mRNA	8q24.11	A21035
Entinostat	Investigational	SLC35D1	23169	downregulated	entinostat results in decreased expression of SLC35D1 mRNA	1p31.3	A21035
Entinostat	Investigational	SLC35D3	340146	upregulated	entinostat results in increased expression of SLC35D3 mRNA	6q23.3	A21037
Entinostat	Investigational	SLC35E2	9906	downregulated	entinostat results in decreased expression of SLC35E2 mRNA	1p36.33	A21037 A21035
Entinostat	Investigational	SLC35E4	339665	upregulated	entinostat results in increased expression of SLC35E4 mRNA	22q12.2	A21035
Entinostat	Investigational	SLC35G2	80723	upregulated	entinostat results in increased expression of SLC35G2 mRNA	3q22.3	A21037
Entinostat	Investigational	SLC38A5	92745	upregulated	entinostat results in increased expression of SLC38A5 mRNA	Xp11.23	A21037 A21035
Entinostat	Investigational	SLC39A14	23516	upregulated	entinostat results in increased expression of SLC39A14 mRNA	8p21.3	A21037
Entinostat	Investigational	SLC3A1	6519	downregulated	entinostat results in decreased expression of SLC3A1 mRNA	2p21	A21035
Entinostat	Investigational	SLC3A2	6520	upregulated	entinostat results in increased expression of SLC3A2 mRNA	11q12.3	A21037
Entinostat	Investigational	SLC41A2	84102	upregulated	entinostat results in increased expression of SLC41A2 mRNA	12q23.3	A21035
Entinostat	Investigational	SLC43A1	8501	upregulated	entinostat results in increased expression of SLC43A1 mRNA	11q12.1	A21037
Entinostat	Investigational	SLC43A3	29015	upregulated	entinostat results in increased expression of SLC43A3 mRNA	11q12.1	A21035
Entinostat	Investigational	SLC44A3	126969	upregulated	entinostat results in increased expression of SLC44A3 mRNA	1p21.3	A21037 A21035
Entinostat	Investigational	SLC46A3	283537	upregulated	entinostat results in increased expression of SLC46A3 mRNA	13q12.3	A21035
Entinostat	Investigational	SLC47A1	55244	upregulated	entinostat results in increased expression of SLC47A1 mRNA	17p11.2	A21037
Entinostat	Investigational	SLC4A11	83959	upregulated	entinostat results in increased expression of SLC4A11 mRNA	20p13	A21037 A21035
Entinostat	Investigational	SLC4A7	9497	downregulated	entinostat results in decreased expression of SLC4A7 mRNA	3p24.1	A21035
Entinostat	Investigational	SLC52A3	113278	upregulated	entinostat results in increased expression of SLC52A3 mRNA	20p13	A21037
Entinostat	Investigational	SLC6A1	6529	upregulated	entinostat results in increased expression of SLC6A1 mRNA	3p25.3	A21035
Entinostat	Investigational	SLC6A8	6535	downregulated	entinostat results in decreased expression of SLC6A8 mRNA	Xq28	A21037
Entinostat	Investigational	SLC7A10	56301	upregulated	entinostat results in increased expression of SLC7A10 mRNA	19q13.11	A21037 A21035
Entinostat	Investigational	SLC7A11	23657	upregulated	entinostat results in increased expression of SLC7A11 mRNA	4q28.3	A21037
Entinostat	Investigational	SLC7A3	84889	upregulated	entinostat results in increased expression of SLC7A3 mRNA	Xq13.1	A21037

Displaying entries 38526 - 38550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability